Published in Proc Soc Exp Biol Med on December 01, 1962
Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation. Appl Microbiol (1969) 4.99
Synthesis of reovirus ribonucleic acid in L cells. J Bacteriol (1965) 2.34
A sigma 1 region important for hemagglutination by serotype 3 reovirus strains. J Virol (1990) 1.57
Transcription of the genomes of type 1 and type 3 reoviruses. J Virol (1968) 1.56
MURINE INFECTION WITH REOVIRUS. 3. PATHOLOGY OF INFECTION WITH TYPES 1 AND 2. Br J Exp Pathol (1965) 1.30
Physiochemical characterization of a neonatal calf diarrhea virus. Can J Comp Med (1973) 1.14
The sweet spot: defining virus-sialic acid interactions. Nat Rev Microbiol (2014) 1.13
Genetic reassortants for identification of the genome segment coding for the bluetongue virus hemagglutinin. J Virol (1987) 1.01
Characterization and serotyping of three feline reovirus isolates. Infect Immun (1974) 0.77
Poliovirus-induced RNA polymerase and the effects of virus-specific inhibitors on its production. Proc Natl Acad Sci U S A (1963) 5.89
STUDIES ON THE MECHANISM OF POLIOVIRUS-INDUCED CELL DAMAGE. I. THE RELATION BETWEEN POLIOVIRUS,-INDUCED METABOLIC AND MORPHOLOGICAL ALTERATIONS IN CULTURED CELLS. Virology (1965) 5.21
Characterization and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med (1950) 4.86
ELECTRON MICROSCOPIC STUDY OF THE FORMATION OF POLIOVIRUS. Virology (1965) 3.71
A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses. J Exp Med (1952) 3.67
Reovirus type 3: physical characteristics and interaction with L cells. Virology (1962) 3.65
Quantitative titration of vaccinia virus on the chorioallantoic membrane. J Immunol (1956) 3.60
The structure of RNA. Reovirus RNA and transfer RNA have similar three-dimensional structures, which differ from DNA. Science (1963) 3.42
Inhibition of influenza virus multiplication by N-glycosides of benzimidazoles-N. J Exp Med (1954) 2.84
ENZYMIC SYNTHESIS OF RNA WITH REOVIRUS RNA AS TEMPLATE. I. CHARACTERISTICS OF THE REACTION CATALYZED BY THE RNA POLYMERASE FROM ESCHERICHIA COLI. J Mol Biol (1964) 2.47
Two kinds of particles with contrasting properties in influenza A virus strains from the 1957 pandemic. Virology (1959) 2.46
Spectrum and characteristics of the virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole. J Exp Med (1961) 2.20
ELECTRON MICROSCOPE STUDIES ON REOVIRUS RNA. Proc Natl Acad Sci U S A (1964) 2.03
Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. II. Measurement of inhibitory activity by hemagglutination titrations. J Exp Med (1953) 2.00
THE UPTAKE AND DEVELOPMENT OF REOVIRUS IN STRAIN L CELLS FOLLOWED WITH LABELED VIRAL RIBONUCLEIC ACID AND FERRITIN-ANTIBODY CONJUGATES. Virology (1965) 1.97
Heterogeneity of Coxsackie B4 virus: two kinds of particles which differ in antibody sensitivity, growth rate, and plaque size. Virology (1962) 1.90
Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. III. Relationship between inhibitory activity and chemical structure. J Exp Med (1953) 1.79
Differences in the selective virus inhibitory action of 2-(alpha-hydroxybenzyl)-benzimidazole and guanidine HCl. Virology (1962) 1.66
A new technique for dropping the chorioallantoic membrane in embryonated chicken eggs. J Lab Clin Med (1955) 1.65
Inhibition of influenza virus multiplication by 2,5-dimethylbenzimidazole. Yale J Biol Med (1952) 1.64
Enumeration of cell-infecting particles of Newcastle disease virus by the fluorescent antibody technique. J Exp Med (1961) 1.64
Fractional dilution procedure for precise titration of hemagglutinating viruses and hemagglutination-inhibiting antibodies. J Immunol (1953) 1.64
SPECIFIC INHIBITION OF REPLICATION OF ANIMAL VIRUSES. Science (1963) 1.62
Ultracentrifugation studies of a urinary mucoprotein which reacts with various viruses. J Biol Chem (1955) 1.60
Studies of two kinds of virus particles which comprise influenza A2 virus strains. II. Reactivity with virus inhibitors in normal sera. J Exp Med (1960) 1.56
Immunological characteristics of N.Y. strains of influenza A virus from the 1957 pandemic. Proc Soc Exp Biol Med (1958) 1.55
Inhibition of influenza and mumps virus multiplication by 4,5,6- (or 5,6,7-) trichloro-1-beta-D-ribofuranosyl-benzimidazole. Science (1954) 1.53
Biochemical basis for alterations in structure and function of HeLa cells infected with Newcastle disease virus. J Exp Med (1961) 1.52
Selective chemical inhibition of influenza B virus multiplication. J Bacteriol (1956) 1.51
Direct visualization of a mucoprotein component of urine. J Biol Chem (1955) 1.50
Reactive sites of reovirus type 3 and their interaction with receptor substances. Virology (1962) 1.47
STUDIES ON THE MECHANISM OF POLIOVIRUS-INDUCED CELL DAMAGE. II. THE RELATION BETWEEN POLIOVIRUS GROWTH AND VIRUS-INDUCED MORPHOLOGICAL CHANGES IN CELLS. Virology (1965) 1.47
ANIMAL AND PLANT VIRUSES WITH DOUBLE-HELICAL RNA. Proc Natl Acad Sci U S A (1963) 1.45
Influenza virus multiplication in the chorioallantoic membrane in vitro: kinetic aspects of inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. J Exp Med (1954) 1.45
On the role of ribonucleic acid in animal virus synthesis. I. Studies with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. J Exp Med (1960) 1.42
Inhibition of influenza virus multiplication by alkyl derivatives of benzimidazole. I. Kinetic aspects of inhibition by 2,5-dimethylbenzimidazole as measured by infectivity titrations. J Exp Med (1953) 1.41
MACROMOLECULAR SYNTHESIS IN REOVIRUS-INFECTED L CELLS. Biochim Biophys Acta (1963) 1.40
High inhibitory activity of certain halogenated ribofuranosylbenzimidazoles on influenza B virus multiplication. J Bacteriol (1956) 1.37
Influenza virus-erythrocyte interaction. I. Reversible reaction between Lee virus and cat erythrocytes. J Immunol (1954) 1.36
Mitosis and division in HeLa cells infected with influenza or Newcastle disease virus. Virology (1959) 1.36
An electrophoretic examination of a urinary mucoprotein which reacts with various viruses. J Exp Med (1952) 1.35
Studies of two kinds of virus particles which comprise influenza A2 virus strains. III. Morphological characteristics: independence to morphological and functional traits. J Exp Med (1960) 1.35
Enhancement of influenza virus multiplication by 5-methyl-2-D-ribobenzimidazole. Virology (1956) 1.32
Multiplication of vaccinia virus in the chorioallantoic membrane in vitro. Virology (1957) 1.28
On the role of ribonucleic acid in animal virus synthesis. II. Studies with ribonuclease. J Exp Med (1960) 1.27
2,(alpha-hydroxybenzyl)-benzimidazole (HBB) as an aid in virus classification. Virology (1961) 1.22
Factors determining pathogenicity of variants of ECHO 9 virus for newborn mice. J Exp Med (1959) 1.21
A new count of allontoic cells of the 10-day chick embryo. Proc Soc Exp Biol Med (1954) 1.16
Effect of multiplicity of infection on Newcastle disease virus-HeLa cell interaction. J Exp Med (1961) 1.16
Measurement of herpes simplex virus by the plaque technique in human amnion cells. J Immunol (1959) 1.12
Comparison of influenza B virus strains from the 1950 epidemic with strains from earlier epidemics. Proc Soc Exp Biol Med (1950) 1.11
COMPLETE AND CORELESS HEMAGGLUTINATING PARTICLES PRODUCED IN ECHO 12 VIRUS-INFECTED CELLS. Virology (1964) 1.11
Equivalence between vaccinia particles counted by electron microscopy and infectious units of the virus. Proc Soc Exp Biol Med (1957) 1.08
COXSACKIE A9 VIRUS: MUTATION FROM DRUG DEPENDENCE TO DRUG INDEPENDENCE. Science (1965) 1.06
Glycosides of chlorobenzimidazoles as inhibitors of poliovirus multiplication. Virology (1957) 1.04
Relationship between structure of benzimidazole derivatives and inhibitory activity on vaccinia virus multiplication. Virology (1957) 1.04
Prevention of virus interference by 2,5-dimethylbenzimidazole. J Immunol (1955) 1.01
[The aldehydes of the glycerophosphatides of skeletal and heart muscle]. Hoppe Seylers Z Physiol Chem (1952) 0.97
THE DRUG-REQUIRING PHASE IN THE GROWTH OF DRUG-DEPENDENT ENTEROVIRUSES. Proc Natl Acad Sci U S A (1963) 0.96
ALTERED LOCATION OF PROTEIN SYNTHESIS IN THE CELL AFTER POLIOVIRUS INFECTION. Biochim Biophys Acta (1963) 0.95
EVIDENCE FOR UNCOUPLED SYNTHESIS OF VIRAL RNA AND VIRAL CAPSIDS. Virology (1964) 0.95
Growth curves of influenza virus based on hemagglutination titers in individual embryonated eggs. Yale J Biol Med (1951) 0.94
RESCUE OF DRUG-REQUIRING AND DRUG-INHIBITED ENTEROVIRUSES. Proc Natl Acad Sci U S A (1964) 0.93
Chemotherapy of viral and rickettsial diseases. Annu Rev Microbiol (1957) 0.92
THE RELATION OF PROTEIN SYNTHESIS TO FORMATION OF POLIOVIRUS RNA POLYMERASE. Virology (1963) 0.91
Base composition of the RNA of a reovirus variant. Science (1963) 0.89
Antiviral chemotherapy. Yale J Biol Med (1956) 0.87
A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses. Arch Gesamte Virusforsch (1961) 0.85
A comparison of some properties of polyoma virus and pneumonia virus of mice. Proc Soc Exp Biol Med (1961) 0.85
SYNERGISTIC EFFECT OF 2-(ALPHA-HYDROXYBENZYL)-BENZIMIDAZOLE AND GUANIDINE ON PICORNAVIRUS REPRODUCTION. Nature (1963) 0.84
SYNTHESIS AND VIRUS-INHIBITORY ACTIVITY OF D- AND L-ISOMERS OF 2-(ALPHA-HYDROXY-BENZYL)-BENZIMIDAZOLE. Nature (1964) 0.83
THE DEVELOPMENT OF ULTRAVIOLET-IRRADIATION RESISTANCE BY POLIOVIRUS INFECTIVE CENTERS AND ITS INHIBITION BY GUANIDINE. Virology (1965) 0.81
[Quantitative investigation on the complement fixation reactions in lymphocytic choriomeningitis]. Arch Gesamte Virusforsch (1958) 0.80
The effect of monochromatic ultraviolet radiation on the infectivity and hemagglutinating ability of the influenza virus type A strain PR-8. J Bacteriol (1950) 0.79
Certain benzimidazoles, benzenes, and ribofuranosylpurines as inhibitors of influenza B virus multiplication. J Bacteriol (1956) 0.77